Lipid treatment assessment project 2: A multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals

David D. Waters, Carlos Brotons, Cheng Wen Chiang, Jean Ferrières, Joanne Foody, J. Wouter Jukema, Raul D. Santos, Juan Verdejo, Michael Messig, Ruth McPherson, Ki Bae Seung, Lisa Tarasenko

Research output: Contribution to journalArticle

240 Citations (Scopus)

Abstract

BACKGROUND-: Information about physicians' adherence to cholesterol management guidelines remains scant. The present survey updates our knowledge of lipid management worldwide. METHODS AND RESULTS-: Lipid levels were determined at enrollment in dyslipidemic adult patients on stable lipid-lowering therapy in 9 countries. The primary end point was the success rate, defined as the proportion of patients achieving appropriate low-density lipoprotein cholesterol (LDL-C) goals for their given risk. The mean age of the 9955 evaluable patients was 62±12 years; 54% were male. Coronary disease and diabetes mellitus had been diagnosed in 30% and 31%, respectively, and 14% were current smokers. Current treatment consisted of a statin in 75%. The proportion of patients achieving LDL-C goals according to relevant national guidelines ranged from 47% to 84% across countries. In low-, moderate-, and high-risk groups, mean LDL-C was 119, 109, and 91 mg/dL and mean high-density lipoprotein cholesterol was 62, 49, and 50 mg/dL, respectively. The success rate for LDL-C goal achievement was 86% in low-, 74% in moderate-, and 67% in high-risk patients (73% overall). However, among coronary heart disease patients with ≤2 risk factors, only 30% attained the optional LDL-C goal of 60 mg/dL in 26% of patients. CONCLUSIONS-: Although there is room for improvement, particularly in very-high-risk patients, these results indicate that lipid-lowering therapy is being applied much more successfully than it was a decade ago.

Original languageEnglish
Pages (from-to)28-34
Number of pages7
JournalCirculation
Volume120
Issue number1
DOIs
Publication statusPublished - Jul 7 2009

Fingerprint

LDL Cholesterol
Lipids
Therapeutics
Coronary Disease
Guidelines
Knowledge Management
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Surveys and Questionnaires
HDL Cholesterol
Diabetes Mellitus
Cholesterol
Physicians

Keywords

  • Hypercholesterolemia
  • Lipids
  • Prevention
  • Statins

ASJC Scopus subject areas

  • Medicine(all)
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Lipid treatment assessment project 2 : A multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. / Waters, David D.; Brotons, Carlos; Chiang, Cheng Wen; Ferrières, Jean; Foody, Joanne; Jukema, J. Wouter; Santos, Raul D.; Verdejo, Juan; Messig, Michael; McPherson, Ruth; Seung, Ki Bae; Tarasenko, Lisa.

In: Circulation, Vol. 120, No. 1, 07.07.2009, p. 28-34.

Research output: Contribution to journalArticle

Waters, DD, Brotons, C, Chiang, CW, Ferrières, J, Foody, J, Jukema, JW, Santos, RD, Verdejo, J, Messig, M, McPherson, R, Seung, KB & Tarasenko, L 2009, 'Lipid treatment assessment project 2: A multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals', Circulation, vol. 120, no. 1, pp. 28-34. https://doi.org/10.1161/CIRCULATIONAHA.108.838466
Waters, David D. ; Brotons, Carlos ; Chiang, Cheng Wen ; Ferrières, Jean ; Foody, Joanne ; Jukema, J. Wouter ; Santos, Raul D. ; Verdejo, Juan ; Messig, Michael ; McPherson, Ruth ; Seung, Ki Bae ; Tarasenko, Lisa. / Lipid treatment assessment project 2 : A multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. In: Circulation. 2009 ; Vol. 120, No. 1. pp. 28-34.
@article{3f2955a8a700476a8b786ab14798b22c,
title = "Lipid treatment assessment project 2: A multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals",
abstract = "BACKGROUND-: Information about physicians' adherence to cholesterol management guidelines remains scant. The present survey updates our knowledge of lipid management worldwide. METHODS AND RESULTS-: Lipid levels were determined at enrollment in dyslipidemic adult patients on stable lipid-lowering therapy in 9 countries. The primary end point was the success rate, defined as the proportion of patients achieving appropriate low-density lipoprotein cholesterol (LDL-C) goals for their given risk. The mean age of the 9955 evaluable patients was 62±12 years; 54{\%} were male. Coronary disease and diabetes mellitus had been diagnosed in 30{\%} and 31{\%}, respectively, and 14{\%} were current smokers. Current treatment consisted of a statin in 75{\%}. The proportion of patients achieving LDL-C goals according to relevant national guidelines ranged from 47{\%} to 84{\%} across countries. In low-, moderate-, and high-risk groups, mean LDL-C was 119, 109, and 91 mg/dL and mean high-density lipoprotein cholesterol was 62, 49, and 50 mg/dL, respectively. The success rate for LDL-C goal achievement was 86{\%} in low-, 74{\%} in moderate-, and 67{\%} in high-risk patients (73{\%} overall). However, among coronary heart disease patients with ≤2 risk factors, only 30{\%} attained the optional LDL-C goal of 60 mg/dL in 26{\%} of patients. CONCLUSIONS-: Although there is room for improvement, particularly in very-high-risk patients, these results indicate that lipid-lowering therapy is being applied much more successfully than it was a decade ago.",
keywords = "Hypercholesterolemia, Lipids, Prevention, Statins",
author = "Waters, {David D.} and Carlos Brotons and Chiang, {Cheng Wen} and Jean Ferri{\`e}res and Joanne Foody and Jukema, {J. Wouter} and Santos, {Raul D.} and Juan Verdejo and Michael Messig and Ruth McPherson and Seung, {Ki Bae} and Lisa Tarasenko",
year = "2009",
month = "7",
day = "7",
doi = "10.1161/CIRCULATIONAHA.108.838466",
language = "English",
volume = "120",
pages = "28--34",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Lipid treatment assessment project 2

T2 - A multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals

AU - Waters, David D.

AU - Brotons, Carlos

AU - Chiang, Cheng Wen

AU - Ferrières, Jean

AU - Foody, Joanne

AU - Jukema, J. Wouter

AU - Santos, Raul D.

AU - Verdejo, Juan

AU - Messig, Michael

AU - McPherson, Ruth

AU - Seung, Ki Bae

AU - Tarasenko, Lisa

PY - 2009/7/7

Y1 - 2009/7/7

N2 - BACKGROUND-: Information about physicians' adherence to cholesterol management guidelines remains scant. The present survey updates our knowledge of lipid management worldwide. METHODS AND RESULTS-: Lipid levels were determined at enrollment in dyslipidemic adult patients on stable lipid-lowering therapy in 9 countries. The primary end point was the success rate, defined as the proportion of patients achieving appropriate low-density lipoprotein cholesterol (LDL-C) goals for their given risk. The mean age of the 9955 evaluable patients was 62±12 years; 54% were male. Coronary disease and diabetes mellitus had been diagnosed in 30% and 31%, respectively, and 14% were current smokers. Current treatment consisted of a statin in 75%. The proportion of patients achieving LDL-C goals according to relevant national guidelines ranged from 47% to 84% across countries. In low-, moderate-, and high-risk groups, mean LDL-C was 119, 109, and 91 mg/dL and mean high-density lipoprotein cholesterol was 62, 49, and 50 mg/dL, respectively. The success rate for LDL-C goal achievement was 86% in low-, 74% in moderate-, and 67% in high-risk patients (73% overall). However, among coronary heart disease patients with ≤2 risk factors, only 30% attained the optional LDL-C goal of 60 mg/dL in 26% of patients. CONCLUSIONS-: Although there is room for improvement, particularly in very-high-risk patients, these results indicate that lipid-lowering therapy is being applied much more successfully than it was a decade ago.

AB - BACKGROUND-: Information about physicians' adherence to cholesterol management guidelines remains scant. The present survey updates our knowledge of lipid management worldwide. METHODS AND RESULTS-: Lipid levels were determined at enrollment in dyslipidemic adult patients on stable lipid-lowering therapy in 9 countries. The primary end point was the success rate, defined as the proportion of patients achieving appropriate low-density lipoprotein cholesterol (LDL-C) goals for their given risk. The mean age of the 9955 evaluable patients was 62±12 years; 54% were male. Coronary disease and diabetes mellitus had been diagnosed in 30% and 31%, respectively, and 14% were current smokers. Current treatment consisted of a statin in 75%. The proportion of patients achieving LDL-C goals according to relevant national guidelines ranged from 47% to 84% across countries. In low-, moderate-, and high-risk groups, mean LDL-C was 119, 109, and 91 mg/dL and mean high-density lipoprotein cholesterol was 62, 49, and 50 mg/dL, respectively. The success rate for LDL-C goal achievement was 86% in low-, 74% in moderate-, and 67% in high-risk patients (73% overall). However, among coronary heart disease patients with ≤2 risk factors, only 30% attained the optional LDL-C goal of 60 mg/dL in 26% of patients. CONCLUSIONS-: Although there is room for improvement, particularly in very-high-risk patients, these results indicate that lipid-lowering therapy is being applied much more successfully than it was a decade ago.

KW - Hypercholesterolemia

KW - Lipids

KW - Prevention

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=67651111687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651111687&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.108.838466

DO - 10.1161/CIRCULATIONAHA.108.838466

M3 - Article

C2 - 19546386

AN - SCOPUS:67651111687

VL - 120

SP - 28

EP - 34

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 1

ER -